Sunday, October 13, 2013

Recall: weight Loss Supplement Contains Life Threatening Drug


B@B Trade, Inc., Florida is voluntarily recalling all lots of Slim Fortune, Lidiy, and Slim Expert to the consumer level. The FDA laboratory analysis of these dietary supplements found to contain undeclared Sibutramine. Sibutramine was a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons, making these products unapproved new drugs.
These products may pose a threat to consumers because Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking. No illnesses or injuries have been reported to B@B Trade, Inc. to date in connection with these products.
The recalled products are packaged in plastic bottles as follows: Slim Fortune green capsules / 30 capsules per bottle, Lidiy green capsules, / 30 capsules per bottle, and Slim Expert 30 softgels capsules per bottle. All these products are marketed as a natural herb for weight loss.
The products were sold directly to individual customers in our Florida, sales office and online at www.lidiy.com, www.slimfortune.com, or www.slimexpert.com. The company has discontinued distribution and sales of these products. It sincerely regrets any inconvenience to our customers. Consumers should not consume Slim Fortune, Lidiy, or Slim Expert Dietary Supplements and should return the products immediately to the place of purchase. Consumers with questions should contact B@B Trade Inc. at 305-763-6956 or via e-mail at interincorp@yahoo.com Monday - Friday, 10:00 am - 4:00 pm, EDT.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.


No comments:

Post a Comment